| one publication added to basket [367631] | Activation of liver X receptors and peroxisome proliferator-activated receptors by lipid extracts of brown seaweeds: a potential application in Alzheimer’s disease?
Martens, N.; Zhan, N.; Voortman, G.; Leijten, F.P.J.; van Rheenen, C.; van Leerdam, S.; Geng, X.; Huybrechts, M.; Liu, H.; Jonker, J.W.; Kuipers, F.; Lütjohann, D.; Vanmierlo, T.; Mulder, M.T. (2023). Activation of liver X receptors and peroxisome proliferator-activated receptors by lipid extracts of brown seaweeds: a potential application in Alzheimer’s disease? Nutrients 15(13): 3004. https://dx.doi.org/10.3390/nu15133004
In: Nutrients. MDPI AG: Basel. e-ISSN 2072-6643, more
|   |
| Keywords |
|
| Author keywords |
nuclear receptor superfamily; liver X receptors; peroxisome proliferator-activated receptors; lipid metabolism; phytosterols; seaweed; Alzheimer’s Disease |
| Authors | | Top |
- Martens, N., more
- Zhan, N.
- Voortman, G.
- Leijten, F.P.J.
- van Rheenen, C.
|
- van Leerdam, S.
- Geng, X.
- Huybrechts, M., more
- Liu, H.
- Jonker, J.W.
|
- Kuipers, F.
- Lütjohann, D.
- Vanmierlo, T., more
- Mulder, M.T.
|
| Abstract |
The nuclear liver X receptors (LXRα/β) and peroxisome proliferator-activated receptors (PPARα/γ) are involved in the regulation of multiple biological processes, including lipid metabolism and inflammation. The activation of these receptors has been found to have neuroprotective effects, making them interesting therapeutic targets for neurodegenerative disorders such as Alzheimer’s Disease (AD). The Asian brown seaweed Sargassum fusiforme contains both LXR-activating (oxy)phytosterols and PPAR-activating fatty acids. We have previously shown that dietary supplementation with lipid extracts of Sargassum fusiforme prevents disease progression in a mouse model of AD, without inducing adverse effects associated with synthetic pan-LXR agonists. We now determined the LXRα/β- and PPARα/γ-activating capacity of lipid extracts of six European brown seaweed species (Alaria esculenta, Ascophyllum nodosum, Fucus vesiculosus, Himanthalia elongata, Saccharina latissima, and Sargassum muticum) and the Asian seaweed Sargassum fusiforme using a dual luciferase reporter assay. We analyzed the sterol and fatty acid profiles of the extracts by GC-MS and UPLC MS/MS, respectively, and determined their effects on the expression of LXR and PPAR target genes in several cell lines using quantitative PCR. All extracts were found to activate LXRs, with the Himanthalia elongata extract showing the most pronounced efficacy, comparable to Sargassum fusiforme, for LXR activation and transcriptional regulation of LXR-target genes. Extracts of Alaria esculenta, Fucus vesiculosus, and Saccharina latissima showed the highest capacity to activate PPARα, while extracts of Alaria esculenta, Ascophyllum nodosum, Fucus vesiculosus, and Sargassum muticum showed the highest capacity to activate PPARγ, comparable to Sargassum fusiforme extract. In CCF-STTG1 astrocytoma cells, all extracts induced expression of cholesterol efflux genes (ABCG1, ABCA1, and APOE) and suppressed expression of cholesterol and fatty acid synthesis genes (DHCR7, DHCR24, HMGCR and SREBF2, and SREBF1, ACACA, SCD1 and FASN, respectively). Our data show that lipophilic fractions of European brown seaweeds activate LXRs and PPARs and thereby modulate lipid metabolism. These results support the potential of brown seaweeds in the prevention and/or treatment of neurodegenerative diseases and possibly cardiometabolic and inflammatory diseases via concurrent activation of LXRs and PPARs. |
|
